trending Market Intelligence /marketintelligence/en/news-insights/trending/u8bmqstltu4nas9suylwtg2 content esgSubNav
In This List

SELLAS Life Sciences appoints Acorda executive as chairman

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


SELLAS Life Sciences appoints Acorda executive as chairman

SELLAS Life Sciences Group Inc. appointed Jane Wasman as chairman of the board.

Wasman is president of international, general counsel and corporate secretary at Acorda Therapeutics Inc., an Ardsley, N.Y.-based developer of neurological therapies.

New York's Sellas Life Sciences develops novel cancer immunotherapies.